0 NYSE Companies - July 23, 2019Myovant Sciences Announces Positive Results from Second Phase 3 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids and Positive Results from Bioequivalence StudyRead More
0 NASDAQ Companies - July 23, 2019Stan Lee's Superhero Kindergarten Introduced to Enthusiastic Crowd at Comic-Con International: San DiegoRead More
0 NASDAQ Companies - July 23, 2019VIVUS to Host Second Quarter Business Update and Financial Results Conference Call on Tuesday, August 6, 2019Read More
0 NASDAQ Companies - July 23, 2019UP Fintech Holding Limited Reports Approval for Capital Markets Licence in SingaporeRead More
0 NASDAQ Companies - July 23, 2019Marathon Patent Group Receives Nasdaq Acceptance of its Plan to Regain ComplianceRead More
0 NASDAQ Companies - July 23, 2019Cytokinetics Granted European Orphan Designation for Reldesemtiv for the Treatment of Spinal Muscular AtrophyRead More
0 NASDAQ Companies - July 23, 2019Idera Pharmaceuticals Announces Appointments of Elizabeth A. Tarka, MD, FACC as Chief Medical Officer and John J. Kirby as Chief Financial OfficerRead More
0 NASDAQ Companies - July 23, 2019Marinus Pharmaceuticals Announces Data from Magnolia and Amaryllis Phase 2 Studies in Women with Postpartum DepressionRead More
0 TSX News - July 23, 2019Aptose To Release Second Quarter Ended June 30, 2019 Financial Results and Hold Conference Call on August 6, 2019Read More
